Carmichael Hill & Associates, Inc. Pfizer Inc Transaction History

Carmichael Hill & Associates, Inc.

$253 Million
Q2 2024

A detailed history of Carmichael Hill & Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 19,631 shares of PFE stock, worth $561,642. This represents 0.22% of its overall portfolio holdings.

Number of Shares

19,631

Previous 19,614 0.09%

Holding current value

$561,642

Previous $544,000 0.92%

% of portfolio

0.22%

Previous 0.22%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$25.26 - $29.6 $429 - $503	17 Added 0.09%	19,631 $549,000
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $64,725 - $74,325	2,500 Added 14.61%	19,614 $544,000
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $16,200 - $21,042	-620 Reduced 3.5%	17,114 $492,000
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $17,906 - $20,930	558 Added 3.25%	17,734 $588,000
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $59,850 - $69,246	1,657 Added 10.68%	17,176 $630,000
Q1 2023 Apr 05, 2023	BUY	$39.39 - $51.28 $20,404 - $26,563	518 Added 3.45%	15,519 $633,000
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $27,346 - $35,697	-655 Reduced 4.18%	15,001 $768,000
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $4,594 - $5,609	105 Added 0.68%	15,656 $685,000
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $42,202 - $50,039	907 Added 6.19%	15,551 $815,000
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $20,038 - $24,830	-438 Reduced 2.9%	14,644 $758,000
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $454 - $673	11 Added 0.07%	15,082 $891,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $5,730 - $7,361	146 Added 0.98%	15,071 $648,000
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $5,637 - $6,386	157 Added 1.06%	14,925 $584,000
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $9,042 - $10,197	270 Added 1.86%	14,768 $535,000
Q4 2020 Jan 27, 2021	BUY	$33.47 - $42.56 $4,618 - $5,873	138 Added 0.96%	14,498 $534,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $12,795 - $15,011	403 Added 2.89%	14,360 $527,000
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $16,566 - $20,097	550 Added 4.1%	13,957 $456,000
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $7,811 - $11,161	-289 Reduced 2.11%	13,407 $438,000
Q4 2019 Jan 30, 2020	BUY	$32.92 - $37.36 $21,628 - $24,545	657 Added 5.04%	13,696 $537,000
Q3 2019 Nov 06, 2019	SELL	$32.49 - $42.13 $6,498 - $8,426	-200 Reduced 1.51%	13,039 $468,000
Q2 2019 Jul 30, 2019	SELL	$36.98 - $41.52 $8,431 - $9,466	-228 Reduced 1.69%	13,239 $574,000
Q1 2019 Apr 23, 2019	SELL	$37.5 - $41.2 $28,200 - $30,982	-752 Reduced 5.29%	13,467 $572,000
Q4 2018 Jan 16, 2019	SELL	$38.47 - $43.86 $36,777 - $41,930	-956 Reduced 6.3%	14,219 $621,000
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $344 - $418	10 Added 0.07%	15,175 $669,000
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $2,374 - $2,531	-72 Reduced 0.47%	15,165 $550,000
Q1 2018 Apr 27, 2018	SELL	$31.91 - $37.02 $26,676 - $30,948	-836 Reduced 5.2%	15,237 $541,000
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $534,587 - $567,216	16,073	16,073 $582,000

Others Institutions Holding PFE

# of Institutions

3,222

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $161B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.

Account

Carmichael Hill & Associates, Inc. Pfizer Inc Transaction History